Futuximab

Futuximab is a chimeric monoclonal antibody targeting non-overlapping epitopes on EGFR. Futuximab has antineoplastic activity[1].

Product Specifications

CAS Number

[1310460-85-5]

UNSPSC

12352203

Target

EGFR

Type

Inhibitory Antibodies

Related Pathways

JAK/STAT Signaling; Protein Tyrosine Kinase/RTK

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/futuximab.html

Purity

98.09

Solubility

10 mM in DMSO

Smiles

[Futuximab]

Molecular Weight

(146.28 kDa)

References & Citations

[1]Stephen T Keir, et al. Sym004-induced EGFR elimination is associated with profound anti-tumor activity in EGFRvIII patient-derived glioblastoma models. J Neurooncol. 2018 Jul;138 (3) :489-498.

Shipping Conditions

Dry Ice

Storage Conditions

Store at -80°C for 2 years

Scientific Category

Inhibitory Antibodies

Clinical Information

Phase 2

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

NBP3-06103C 0.1 mL

Rabbit Polyclonal HOXA10 Antibody [DyLight 650]

Ask

View Details

MBS9006816 Inquire

Rabbit anti-Arabidopsis thaliana (Mouse-ear cress) TRX9 Polyclonal Antibody

Ask

View Details

MBS7011011-01 0.02 mg

Recombinant Macaca fascicularis C-C chemokine receptor type 3 (CCR3)

Ask

View Details

MBS7011011-02 0.1 mg

Recombinant Macaca fascicularis C-C chemokine receptor type 3 (CCR3)

Ask

View Details

MBS7011011-03 5x 0.1 mg

Recombinant Macaca fascicularis C-C chemokine receptor type 3 (CCR3)

Ask

View Details

322505 100 µL

LMTK2

Ask

View Details